1.0Pharmacology/pharmBetsy Clarke/pharm/author/bclarke/rich600338<blockquote class="wp-embedded-content" data-secret="k9tzgI6urd"><a href="/pharm/directory/leon-coleman-md-phd/">Leon Coleman, MD, PhD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/pharm/directory/leon-coleman-md-phd/embed/#?secret=k9tzgI6urd" width="600" height="338" title="“Leon Coleman, MD, PhD” — Pharmacology" data-secret="k9tzgI6urd" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> /pharm/wp-content/uploads/sites/930/2019/04/Coleman-photo-CR2-200x230-3S-1.jpg200230Research Interests Immune mechanisms in drug addiction and critical illness, neurodegeneration, extracellular vesicle signaling Research Synopsis The overriding goal of Dr. Coleman’s work is to identify novel treatments for alcohol use disorders (AUD) and associated peripheral disease pathologies.  Currently, this includes: Neuroimmune Signaling in AUD The goal of this project is to determine the role … Read more